Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01651208 · ClinicalTrials.gov registry record · NA
Improving Adherence to Post PCI Antiplatelet Therapy in Minority Populations
A NA study of Coronary Artery Disease, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 452
- Enrollment target
- 1
- Study location
NCT01651208: Completed NA study of Coronary Artery Disease, sponsored by University of Miami.
NCT01651208 is a NA study of Coronary Artery Disease that has completed, run by University of Miami. The registered enrollment target is 452 participants, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01651208, a NA study of Coronary Artery Disease, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 452 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate if the use of a phone based motivational interviewing among minority populations who received a coronary stent can improve adherence to antiplatelet agents from approximately 51% to 66% (15 percentage point increase) at 12 months post stent placement when compared to a mailed educational DVD.
Primary Outcome
Medication Possession ratio (MPR) is a continuous multiple interval measure of medication availability. This is a validated method of estimating medication adherence . The medication possession ratio is defined as the sum of the days' supply of medication divided by the number of days between the first fill and the last refill plus the days' supply of the last refill.We will use the previously validated cutpoint of MPR\>=.80 to define the binary outcome of Appropriate Adherence
Conditions Studied
Interventions
- BEHAVIORAL Motivational Interviewing (MINT)
- BEHAVIORAL Mailed DVD
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 452 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-06 |
| Phase | NA |
What the finished NCT01651208 record still lists
NCT01651208 is an interventional study that assigns participants to a tested intervention. The registered 452 participants enrollment target is mid-sized for trials with a published cap, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which Motivational Interviewing (MINT) is the first listed.
NCT01651208 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01651208 about?
NCT01651208 is a clinical study titled "Improving Adherence to Post PCI Antiplatelet Therapy in Minority Populations". The purpose of this study is to evaluate if the use of a phone based motivational interviewing among minority populations who received a coronary stent can improve adherence to antiplatelet agents from approximately 51% to 66% (15 percentage point increase) at 12 months post stent placement when com...
What is the current status of trial NCT01651208?
This trial is currently completed. It is a NA study. The enrollment target is 452 participants. The study started on 2010-01. Estimated completion is 2012-06.
What conditions does trial NCT01651208 study?
This clinical trial studies the following conditions: Coronary Artery Disease.
What interventions are being tested in trial NCT01651208?
The interventions under investigation include: Motivational Interviewing (MINT) (BEHAVIORAL), Mailed DVD (BEHAVIORAL).
Who is sponsoring clinical trial NCT01651208?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01651208 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01651208's enrollment target sits among peer trials
452 78th of 219 higher than 142 of 219 other Coronary Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
-
Intravascular Lithotripsy With or Without Rotational Atherectomy for Coronary Calcified Nodule Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05676255 · 452 participants · Phase 2
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
- NCT05703178 · 452 participants · Phase 3
Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia
- NCT03460977 · 453 participants · Phase 1
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- NCT04708171 · 453 participants
The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia